%A Qian Menlong, Lu Ning %T Relationship between lymphocytemonocyte ratio and prognosis of malignant tumors %0 Journal Article %D 2016 %J Journal of International Oncology %R 10.3760/cma.j.issn.1673-422X.2016.10.011 %P 769-771 %V 43 %N 10 %U {https://gjzlx.sdfmu.edu.cn/CN/abstract/article_10067.shtml} %8 2016-10-08 %X Related studies have been confirmed that tumorassociated inflammation is associated with tumor progression and prognosis in a variety of tumors. As an inflammatory biomarker, lymphocytemonocyte ratio shows significant value in predicting the prognosis of malignant tumors. It can not only be appropriate for patients with cancer risk stratification, but also provide the basis for the subsequent development of individualized treatment programs.